pdufa.bio
CalendarDecisionsReadoutsPatents
Drug IndexStocksScreenerConferencesAdvisory Committees
StudiesRun-up by YearLearnGlossaryMethodologyAPIAccount
Pro
Home › 2026 Clinical Trial Readout Calendar

2026 Clinical Trial Readout Calendar

By therapeutic area: oncology readouts · rare disease readouts

Updated ·next FDA decision on the calendar

This page lists 285 expected clinical trial readouts covering June 2026 to December 2027. These dates come from company guidance and ClinicalTrials.gov, so most are known only to a month or a quarter, and we publish them at that precision rather than guessing a day.

Upcoming Phase 1/2/3 data readouts: company, drug, indication, and the registered trial. Dates are estimated primary-completion windows from ClinicalTrials.gov, not fixed announcements: they shift. Tap any row for the trial record.
PDUFA datesTrial readoutsDevices
14Jun '2633Jul40Aug47Sep41Oct31Nov103Dec36Jan '2722Feb45Mar27Apr26May48Jun21Jul41Aug33Sep26Oct21Nov42Dec
Upcoming readouts per month (dated estimates; quarter/half-year-only items not charted).
Company-guided readouts

These 57 dates are not trial-registry estimates. Each one is timing the company itself stated in an SEC filing, and each row links to that filing so you can read the sentence it came from. Dates are shown at the precision the company used: a quarter stays a quarter rather than being rendered as a specific day it never named. Guidance that was vaguer than a quarter is not on this page at all.

GuidedTickerProgramCompanySource
Q3 2026AARDARD-101 Aardvark Therapeutics, Inc.EX-99.2 2026-02-12
✓ Reported 2026-08-10
positive +43.5% day-of · company release
ABCLABCL635 AbCellera Biologics Inc.EX-99.2 2026-05-11
Q3 2026ALMSanifrolumab Alumis Inc.EX-99.1 2026-06-29
Q3 2026ALZNAL001 Alzamend Neuro, Inc.10-K 2026-07-22
Q3 2026BOLTBDC-4182 Bolt Biotherapeutics, Inc.EX-99.1 2026-03-12
Q3 2026DFTXDT120 Definium Therapeutics, Inc.424B5 2026-06-24
Q3 2026EVMNEVO756 Evommune, Inc.EX-99.1 2026-06-29
Q3 2026GPCRACCG-2671 Structure Therapeutics Inc.EX-99.1 2026-05-07
Q3 2026IMMXNXC-201 Immix Biopharma, Inc.8-K 2026-03-30
Q3 2026IRONDISC-3405 Disc Medicine, Inc.EX-99.1 2026-07-30
Q3 2026KODKSI-501 Kodiak Sciences Inc.EX-99.1 2026-05-07
Sep 2026MBRXAnnamycin Moleculin Biotech, Inc.EX-99.1 2026-07-31
Q3 2026MNKDMNKD-201 MannKind CorporationEX-99.1 2026-05-06
Q3 2026OCGNOCU400 Ocugen, Inc.EX-99.1 2026-05-04
Q3 2026PHVSdeucrictibant Pharvaris N.V.EX-99.1 2026-06-11
Q3 2026PMNPMN310 ProMIS Neurosciences Inc.EX-99.1 2026-05-12
Q3 2026PPBTIM1305 Purple Biotech Ltd.EX-99.1 2026-03-19
Sep 2026ROIVbrepocitinib Roivant Sciences Ltd.10-K 2026-05-20
Q3 2026SCYXSCY-247 Scynexis IncEX-10.1 2026-05-11
Q3 2026STTKSL-846 Shattuck Labs, Inc.EX-99.3 2026-06-09
Q3 2026SYRESPY001 Spyre Therapeutics, Inc.EX-99.1 2026-05-05
Q3 2026TECXTX2100 Tectonic Therapeutic, Inc.EX-99.1 2026-05-07
Q3 2026VKTXVK2735 Viking Therapeutics, Inc.n/a
Q3 2026VTGNfasedienol Vistagen Therapeutics, Inc.EX-99.1 2026-06-15
Q3 2026WHWKHWK-007 Whitehawk Therapeutics, Inc.EX-99.1 2026-05-07
Q3 2026XENEXEN1701 Xenon Pharmaceuticals Inc.EX-99.1 2026-05-07
Q4 2026ALNYelebsiran Alnylam Pharmaceuticals, Inc.10-K 2026-02-12
Q4 2026ATAIVLS-01 AtaiBeckley Inc.EX-99.1 2026-05-12
Q4 2026BMEABMF-650 Biomea Fusion, Inc.EX-99.1 2026-05-11
Q4 2026CMPXCTX-10726 Compass Therapeutics, Inc.EX-99.1 2026-05-05
Dec 2026CRISNCT07271667 Curis Inc10-Q 2026-05-13
Q4 2026ENTAEDP-978 Enanta Pharmaceuticals Inc424B5 2026-07-02
Q4 2026HELPHLP003 Cybin Inc.EX-99.1 2026-08-03
Q4 2026IPSCCNTY-813 Century Therapeutics, Inc.EX-99.1 2026-06-08
Q4 2026KYNBFG-3246 Kyntra Bio, Inc.10-Q 2026-05-12
Q4 2026LONAATH-1105 LeonaBio, Inc.EX-99.1 2026-05-07
Q4 2026MIRMAZURE-1 Mirum Pharmaceuticals, Inc.EX-99.1 2026-05-06
Q4 2026MTVADA-1726 MetaVia Inc.EX-99.1 2026-04-10
Q4 2026PCVXOPUS-1 Vaxcyte, Inc.EX-99.1 2026-05-06
Q4 2026RAPPRAP-219 Rapport Therapeutics, Inc.EX-99.1 2026-05-07
Q4 2026RGNXRGX-314 REGENXBIO Inc.EX-99.1 2026-06-29
Q4 2026SKYEnimacimab Skye Bioscience, Inc.10-Q 2026-05-11
Q4 2026SLGLSGT-610 Sol-Gel Technologies Ltd.EX-99.1 2026-05-28
Q4 2026SLSSLS009 SELLAS Life Sciences Group, Inc.EX-99.1 2026-05-12
Q4 2026SLSgalinpepimut-S (GPS) event-drivenSELLAS Life Sciences Group, Inc.EX-99.1 2026-05-12
Q4 2026SNDXSNDX-62122 Syndax Pharmaceuticals IncEX-99.1 2026-07-14
Q4 2026TRAXANB033 First Tracks Biotherapeutics, Inc.EX-99.1 2026-05-14
Q4 2026TTRXGX-03 Turn Therapeutics Inc.EX-99.1 2026-07-28
Q4 2026ZBIOZB021 Zenas BioPharma, Inc.EX-99.1 2026-05-13
Q1 2027AKTSAKY-1189 Aktis Oncology, Inc.EX-99.1 2026-05-11
Q1 2027CRBPCRB-701 Corbus Pharmaceuticals Holdings, Inc.10-Q 2026-05-12
Q1 2027NMRANMRA-511 Neumora Therapeutics, Inc.EX-99.1 2026-05-07
Q1 2027OCULHELIOS-3 Ocular Therapeutix, Inc10-Q 2026-05-05
Q1 2027QNCXLAM-001 Quince Therapeutics, Inc.EX-99.4 2026-07-30
Q2 2027PROKREGEN-006 Prokidney Corp.EX-99.2 2026-05-15
Q4 2027KLRSTH103 Kalaris Therapeutics, Inc.EX-99.2 2026-07-17
2027-12-31TYRASURF303 Tyra Biosciences, Inc.EX-99.1 2026-05-13
Reported & confirmed: day-of stock reaction
Outcome and date confirmed against the company's own release (linked per row); reaction is the Polygon-adjusted close vs the prior close. Facts only, not investment advice.
MRK · 2026-08-19 ✓ positive
Intismeran autogene + Keytruda · day-of close reaction, confirmed against the company release
+12.6%
MRNA · 2026-08-19 ✓ positive
Intismeran autogene + Keytruda · day-of close reaction, confirmed against the company release
+177.0%
AMLX · 2026-08-18 ✓ positive
Avexitide (Ph3 LUCIDITY, PBH) · day-of close reaction, confirmed against the company release
+63.8%
ABCL · 2026-08-10 ✓ positive
ABCL635 · day-of close reaction, confirmed against the company release
+43.5%
TENX · 2026-08-10 primary endpoint not met
TNX-103 (oral levosimendan), Ph3 L · day-of close reaction, confirmed against the company release
-89.8%
MPLT · 2026-07-27 ✓ positive
ML-007C-MA, Ph2 ZEPHYR (schizophre · day-of close reaction, confirmed against the company release
-72.9%
Recently reported: stock move over the estimated readout window
Auto-logged: each stock's price move across its estimated readout window (Polygon daily closes). These are estimated month windows, so the exact announcement date and clinical outcome are not yet verified: this shows the market's move over the window, not a statement about trial success. Methodology.
ACRS · Aug 2026
A-101
+15%
AKBA · Aug 2026
Vadadustat
-24%
APGE · Aug 2026
APG777
+1%
BIVI · Aug 2026
NE3107
+46%
BMRN · Aug 2026
Vosoritide
+10%
CLRB · Aug 2026
NOV-002
-2%
GRFS · Aug 2026
ALPHA-1 MP
+1%
IVVD · Aug 2026
VYD2311
+35%
KPTI · Aug 2026
Selinexor
-75%
MANE · Aug 2026
VDPHL01
-12%
MRK · Aug 2026
Ensifentrine
+15%
NVO · Aug 2026
Semaglutide
-6%
TMO · Aug 2026
MK-7240
+10%
VSTM · Aug 2026
avutometinib
+35%
AMGN · Jul 2026
Tezepelumab
+15%
ANIP · Jul 2026
Yutiq
-1%
ARDX · Jul 2026
Tenapanor
-20%
AXSM · Jul 2026
AXS-14
-11%
CERS · Jul 2026
S-303 Treated Red Blood Cells
-19%
CRDF · Jul 2026
Onvansertib
-21%
DWTX · Jul 2026
Halneuron
+18%
ELVN · Jul 2026
ELVN-002
+23%
EXEL · Jul 2026
Cabozantinib
-2%
EYPT · Jul 2026
EYP-1901
-6%
ILMN · Jul 2026
18F-MFBG
+9%
IOVA · Jul 2026
Lifileucel plus Pembrolizumab
+48%
JAZZ · Jul 2026
Lurbinectedin
+13%
JSPR · Jul 2026
Briquilimab
+46%
JSPR · Jul 2026
Briquilimab
+46%
LTRN · Jul 2026
Tavocept(BNP7787) in combination with cisplatin
-24%
OGN · Jul 2026
150μg CFA (Elonva®) at stimulation day (SD) 1 an
+1%
PTCT · Jul 2026
PTC923
-16%
RARE · Jul 2026
GTX-102
-12%
SMMT · Jul 2026
Ivonescimab
-5%
AGIO · Jun 2026
Mitapivat
+32%
AGMB · Jun 2026
AGMB-129
+22%
ARDX · Jun 2026
Tenapanor
-15%
BMY · Jun 2026
Nivolumab
-2%
CELC · Jun 2026
Gedatolisib
-19%
CLLS · Jun 2026
UCART22
-10%
September 2026
AVIR · Sep 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
Awaiting dataupdated 7mo ago
ARVN · Sep 2026 (est.)
ARV-471: Breast Cancer
Awaiting dataupdated 5mo ago
ARDX · Sep 2026 (est.)
Tenapanor: Irritable Bowel Syndrome With Constipation (IBS-C)
Awaiting data
GILD · Sep 2026 (est.)
Sacituzumab Govitecan: Non-small Cell Lung Cancer
EXEL · Sep 2026 (est.)
Cabozantinib: RCC
CORT · Sep 2026 (est.)
Relacorilant: Nonalcoholic Steatohepatitis (NASH)
Awaiting data
CGEM · Sep 2026 (est.)
CLN-081: Multiple Myeloma
Awaiting dataupdated 9mo ago
BHVN · Sep 2026 (est.)
Taldefgrobep Alfa: Obesity
Awaiting data
KPTI · Sep 2026 (est.)
Selinexor: Myelofibrosis
Awaiting data
IRON · Sep 2026 (est.)
DISC-1459: Erythropoietic Protoporphyria (EPP)
Awaiting data
APGE · Sep 2026 (est.)
APG777: Asthma
Awaiting dataupdated 4mo ago
GPCR · Sep 2026 (est.)
aleniglipron: Obese
Awaiting data
VERA · Sep 2026 (est.)
Atacicept: IgA Nephropathy (IgAN)
Awaiting data
SUPN · Sep 2026 (est.)
SPN-812: Attention-Deficit/Hyperactivity Disorder
Awaiting dataupdated 12mo ago
SNDX · Sep 2026 (est.)
Revumenib: Idiopathic Pulmonary Fibrosis
Awaiting data
SLN · Sep 2026 (est.)
SLN124: Polycythemia Vera
Awaiting dataupdated 6mo ago
AGMB · Sep 2026 (est.)
AGMB-129: Fibrostenotic Crohn's Disease
WVE · Sep 2026 (est.)
WVE-210201: Alpha-1 Antitrypsin Deficiency
Awaiting data
MRK · Sep 2026 (est.)
Pembrolizumab: Metastatic Triple-Negative Breast Cancer
BMY · Sep 2026 (est.)
Bevacizumab: Advanced Solid Tumors
BIIB · Sep 2026 (est.)
Litifilimab: Lupus Erythematosus, Systemic
Awaiting dataupdated 5mo ago
MLTX · Sep 2026 (est.)
Sonelokimab: Hidradenitis Suppurativa
Awaiting data
OCGN · Sep 2026 (est.)
OCU410ST: Stargardt Disease
Awaiting data
ILMN · Sep 2026 (est.)
18F-MFBG: Parkinson Disease (PD)
IBRX · Sep 2026 (est.)
ALT-803: Non-muscle Invasive Bladder Cancer
Awaiting data
ALEC · Sep 2026 (est.)
AL001: Alzheimer's Disease
Awaiting dataupdated 7mo ago
EXEL · Sep 2026 (est.)
Cabozantinib: High Grade Neuroendocrine Neoplasms
Awaiting data
CCCC · Sep 2026 (est.)
Cemsidomide: Multiple Myeloma
Awaiting data
BIIB · Sep 2026 (est.)
Litifilimab: Lupus Erythematosus, Systemic
Awaiting dataupdated 5mo ago
IMMP · Sep 2026 (est.)
eftilagimod alfa: Solid Tumors
Awaiting dataupdated 4mo ago
October 2026
OGN · Oct 2026 (est.)
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5: Plaque Psoriasis
Awaiting data
PFE · Oct 2026 (est.)
Palbociclib: Metastatic Renal Cell Carcinoma
ABOS · Oct 2026 (est.)
sabirnetug: Alzheimer Disease
Awaiting dataupdated 8mo ago
MIRM · Oct 2026 (est.)
Maralixibat, Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
Awaiting data
CLDX · Oct 2026 (est.)
Barzolvolimab: Chronic Spontaneous Urticaria
Awaiting data
EYPT · Oct 2026 (est.)
EYP-1901: Wet Age Related Macular Degeneration
Awaiting data
HUMA · Oct 2026 (est.)
Human Acellular Vessel: End Stage Renal Disease (ESRD)
Awaiting data
IMVT · Oct 2026 (est.)
IMVT-1402: Subacute Cutaneous Lupus Erythematosus
Awaiting data
TECX · Oct 2026 (est.)
TX000045- Dose A: Pulmonary Hypertension
Awaiting data
SLDB · Oct 2026 (est.)
SGT-003: Duchenne Muscular Dystrophy
Awaiting data
INCY · Oct 2026 (est.)
Povorcitinib: Prurigo Nodularis
BIIB · Oct 2026 (est.)
Litifilimab: Subacute Cutaneous Lupus Erythematosus
Awaiting data
CSLLY · Oct 2026 (est.)
Recombinant Single-Chain Factor Viii: Congenital Hemophilia A
Awaiting data
SNY · Oct 2026 (est.)
Venglustat: Gaucher Disease Type 1
MRK · Oct 2026 (est.)
Pembrolizumab: Metastatic Uveal Melanoma
INBX · Oct 2026 (est.)
INBRX-106: Solid Tumor
Awaiting dataupdated 6mo ago
VTRS · Oct 2026 (est.)
Cenerimod: Lupus Erythematosus, Systemic
Awaiting data
JSPR · Oct 2026 (est.)
Briquilimab: Chronic Spontaneous Urticaria
Awaiting dataupdated 5mo ago
MRK · Oct 2026 (est.)
IMG-7289: Essential Thrombocythemia
RCUS · Oct 2026 (est.)
Zimberelimab: Non Small Cell Lung Cancer
Awaiting data
RYTM · Oct 2026 (est.)
Setmelanotide: Prader-Willi Syndrome
Awaiting dataupdated 4mo ago
SRPT · Oct 2026 (est.)
Eteplirsen: Muscular Dystrophy, Duchenne
Awaiting dataupdated 4mo ago
SYRE · Oct 2026 (est.)
SPY001: Rheumatoid Arthritis
Awaiting data
ANNX · Oct 2026 (est.)
Tanruprubart: Geographic Atrophy
Awaiting data
IMMP · Oct 2026 (est.)
eftilagimod alfa: Breast Carcinoma
Awaiting dataupdated 19mo ago
November 2026
ATOS · Nov 2026 (est.)
Z-Endoxifen: Breast Neoplasms
Awaiting data
APGE · Nov 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
ERAS · Nov 2026 (est.)
Naporafenib: Advanced or Metastatic Solid Tumors
Awaiting data
IMUX · Nov 2026 (est.)
IMU-838 tablets: Multiple Sclerosis
Awaiting dataupdated 4mo ago
IOVA · Nov 2026 (est.)
Lifileucel plus Pembrolizumab: Metastatic Melanoma
Awaiting dataupdated 10mo ago
ONC · Nov 2026 (est.)
BGB-11417: Relapsed/Refractory Multiple Myeloma
TYRA · Nov 2026 (est.)
TYRA-300: Locally Advanced Urothelial Carcinoma
Awaiting dataupdated 5mo ago
VIR · Nov 2026 (est.)
Bulevirtide: Viral Hepatitis
Awaiting dataupdated 5mo ago
VXRT · Nov 2026 (est.)
VXA-COV2-3.3: SARS-CoV2
Awaiting data
ZURA · Nov 2026 (est.)
Tibulizumab: Hidradenitis Suppurativa (HS)
Awaiting data
ELTX · Nov 2026 (est.)
ELI-002 7P: Pancreatic Ductal Adenocarcinoma
Awaiting data
CRDF · Nov 2026 (est.)
Onvansertib: Metastatic Colorectal Cancer
Awaiting data
BYSI · Nov 2026 (est.)
Docetaxel + Plinabulin: Multiple Myeloma
Awaiting dataupdated 6mo ago
CGEM · Nov 2026 (est.)
CLN-081: NHL
Awaiting dataupdated 26mo ago
PHAR · Nov 2026 (est.)
Leniolisib: APDS
Awaiting data
SNY · Nov 2026 (est.)
Rilzabrutinib: Immune Thrombocytopenia
December 2026
CNTA · Dec 2026 (est.)
cleminorexton: Narcolepsy Type 1
BEAM · Dec 2026 (est.)
BEAM-302: Lymphoblastic Lymphoma
Awaiting dataupdated 18mo ago
BIIB · Dec 2026 (est.)
Felzartamab: Antibody-mediated Rejection
Awaiting data
BMY · Dec 2026 (est.)
Nivolumab: Non Small Cell Lung Cancer
CMPX · Dec 2026 (est.)
CTX-009: Biliary Tract Cancer
Awaiting data
CORT · Dec 2026 (est.)
Relacorilant: Cushing Syndrome
Awaiting data
BCDA · Dec 2026 (est.)
Autologous cell therapy: Heart Failure, Systolic
Awaiting dataupdated 7mo ago
AGEN · Dec 2026 (est.)
Balstilimab: Refractory Metastatic Colorectal Cancer
Awaiting dataupdated 8mo ago
ALMS · Dec 2026 (est.)
Open-Label Envudeucitinib: Plaque Psoriasis
Awaiting data
APGE · Dec 2026 (est.)
APG777: Atopic Dermatitis
Awaiting data
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir: HEPATITIS C VIRUS CHRONIC INFECTION
Awaiting data
MDGL · Dec 2026 (est.)
Resmetirom: NASH
Awaiting data
MRK · Dec 2026 (est.)
Pembrolizumab: Squamous Cell Cancer of Head and Neck
ONC · Dec 2026 (est.)
Zanubrutinib: Waldenstrom Macroglobulinemia
PBYI · Dec 2026 (est.)
neratinib: Breast Cancer
Awaiting data
PFE · Dec 2026 (est.)
Elranatamab: Multiple Myeloma
PHAT · Dec 2026 (est.)
Vonoprazan: Eosinophilic Esophagitis
Awaiting data
RGNX · Dec 2026 (est.)
Ranibizumab: AMD
Awaiting data
RNAC · Dec 2026 (est.)
Decartes-08: Systemic Lupus Erythematosus (SLE)
Awaiting data
MANE · Dec 2026 (est.)
VDPHL01: Androgenetic Alopecia
Awaiting dataupdated 4mo ago
LXEO · Dec 2026 (est.)
LX1001: Arrhythmogenic Cardiomyopathy
Awaiting dataupdated 8mo ago
GOSS · Dec 2026 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INO · Dec 2026 (est.)
VGX-3100: BRCA1/2 Mutation
Awaiting dataupdated 4mo ago
IONS · Dec 2026 (est.)
Donidalorsen: Hereditary Angioedema
Awaiting dataupdated 7mo ago
IXHL · Dec 2026 (est.)
IHL-42X Low Dose: Obstructive Sleep Apnea
Awaiting dataupdated 14mo ago
KPTI · Dec 2026 (est.)
Rituximab: Relapsed/Refractory Diffuse Large B-cell Lymphoma
Awaiting data
TRAW · Dec 2026 (est.)
rigosertib: Influenza
Awaiting data
SNDX · Dec 2026 (est.)
Revumenib: Leukemia
XNCR · Dec 2026 (est.)
XMAB20717: Biliary Tract Cancer
Awaiting dataupdated 9mo ago
PFE · Dec 2026 (est.)
Mevrometostat: Metastatic Castration-Resistant Prostate Cancer
CRDF · Dec 2026 (est.)
Onvansertib: Breast Cancer
Awaiting dataupdated 4mo ago
SNY · Dec 2026 (est.)
Rilzabrutinib: Focal Segmental Glomerulosclerosis
SUPN · Dec 2026 (est.)
BIS-001: Focal Impaired Awareness Seizures
Awaiting dataupdated 47mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting dataupdated 5mo ago
MNOV · Dec 2026 (est.)
MN-166: Diabetes Mellitus, Type 2
Awaiting dataupdated 5mo ago
PFE · Dec 2026 (est.)
Palbociclib: Breast Cancer
VIR · Dec 2026 (est.)
Tobevibart: Viral Hepatitis
Awaiting data
ACTU · Dec 2026 (est.)
Losartan: Pancreatic Adenocarcinoma
Awaiting data
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine: Chronic Lymphocytic Leukemia
Awaiting dataupdated 9mo ago
ARVN · Dec 2026 (est.)
ARV-471: Breast Cancer
Awaiting data
NVO · Dec 2026 (est.)
Semaglutide: Intestinal Mucositis
INSM · Dec 2026 (est.)
Treprostinil Palmitil Inhalation Powder: Pulmonary Arterial Hypertension
Awaiting data
INO · Dec 2026 (est.)
VGX-3100: Glioblastoma
Awaiting data
H2 2026 (est.)
QTTB · H2 2026
bempikibart: Alopecia Areata
FDMT · H2 2026
4D-150 IVT: Macular Neovascularization Secondary to Age-Related Macular Degeneration
NTLA · H2 2026
NTLA-2002: Hereditary Angioedema
PCVX · H2 2026
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
PHVS · H2 2026
deucrictibant: Hereditary Angioedema
SION · H2 2026
SION-719: Cystic Fibrosis (CF)
ZNTL · H2 2026
Investigator's choice of Chemotherapy: Ovarian Cancer
AURA · H2 2026
Bel-sar: Choroidal Melanoma
SABS · H2 2026
SAB-142
KPTI · H2 2026
EX-99
ANRO · H2 2026
EX-99
VRDN · H2 2026
VRDN-008
ADCT · H2 2026
rituximab
NGNE · H2 2026
NGN-401
Q3 2026 (est.)
ALMS · Q3 2026
Open-Label Envudeucitinib: Plaque Psoriasis
ZURA · Q3 2026
Tibulizumab: Systemic Sclerosis (SSc)
AMLX · Q3 2026
AMX0035: Progressive Supranuclear Palsy
Q4 2026 (est.)
CLDX · Q4 2026
Barzolvolimab: Chronic Inducible Urticaria
RGNX · Q4 2026
Ranibizumab: AMD
IRON · Q4 2026
DISC-1459: Erythropoietic Protoporphyria
HELP · Q4 2026
CYB003: Major Depressive Disorder
ATAI · Q4 2026
BPL-003
January 2027
ELVN · Jan 2027 (est.)
ELVN-002: HER2-positive Breast Cancer
Awaiting dataupdated 7mo ago
EXEL · Jan 2027 (est.)
Cabozantinib: Germ Cell Tumor
Awaiting dataupdated 5mo ago
PCVX · Jan 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
RARE · Jan 2027 (est.)
Setrusumab: Osteogenesis Imperfecta
Awaiting data
SIGA · Jan 2027 (est.)
Tecovirimat Oral Capsule: Smallpox
Awaiting data
CADL · Jan 2027 (est.)
Aglatimagene Besadenovec: Malignant Glioma of Brain
Awaiting dataupdated 4mo ago
BMY · Jan 2027 (est.)
Nivolumab: Hodgkin Lymphoma
REGN · Jan 2027 (est.)
Odronextamab: Follicular Lymphoma
OCUL · Jan 2027 (est.)
Otx-Tki: Neovascular Age-related Macular Degeneration
Awaiting dataupdated 12mo ago
GILD · Jan 2027 (est.)
MK-3475: Carcinoma, Non-Small-Cell Lung
IDYA · Jan 2027 (est.)
Darovasertib: Metastatic Uveal Melanoma
Awaiting dataupdated 4mo ago
APLM · Jan 2027 (est.)
Uproleselan: Metastatic Non Small Cell Lung Cancer
Awaiting dataupdated 5mo ago
February 2027
SNDX · Feb 2027 (est.)
Revumenib: Acute Myeloid Leukemias
Awaiting data
MRK · Feb 2027 (est.)
Pembrolizumab: Triple Negative Breast Cancer
KYTX · Feb 2027 (est.)
Standard of Care Treatment: Idiopathic Inflammatory Myopathies
Awaiting dataupdated 4mo ago
MLTX · Feb 2027 (est.)
Sonelokimab: Arthritis, Psoriatic
Awaiting data
OCGN · Feb 2027 (est.)
OCU410ST: Retinitis Pigmentosa
Awaiting dataupdated 4mo ago
AZN · Feb 2027 (est.)
R-Chop: Diffuse Large B-Cell Lymphoma
March 2027
NUVB · Mar 2027 (est.)
safusidenib: Advanced Solid Tumor
Awaiting dataupdated 5mo ago
OCGN · Mar 2027 (est.)
OCU410ST: Retinitis Pigmentosa
Awaiting dataupdated 11mo ago
ONC · Mar 2027 (est.)
Zanubrutinib: Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
Awaiting data
PCVX · Mar 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
AGIO · Mar 2027 (est.)
Mitapivat: Chondrosarcoma
Awaiting data
IPHA · Mar 2027 (est.)
Monalizumab: Metastatic Cancer
Awaiting data
MDGL · Mar 2027 (est.)
Resmetirom: Non-Alcoholic Fatty Liver Disease
Awaiting data
IONS · Mar 2027 (est.)
Olezarsen: Severe Hypertriglyceridemia
Awaiting dataupdated 7mo ago
COGT · Mar 2027 (est.)
CGT9486: Intrahepatic Cholangiocarcinoma (Icc)
Awaiting data
DNLI · Mar 2027 (est.)
BIIB122: Parkinson Disease
Awaiting data
TSHA · Mar 2027 (est.)
TSHA-101: Infantile GM2 Gangliosidosis (Disorder)
Awaiting dataupdated 38mo ago
GILD · Mar 2027 (est.)
Sacituzumab Govitecan: HER2-negative Breast Cancer
CLDX · Mar 2027 (est.)
Barzolvolimab: Glioblastoma
Awaiting data
April 2027
CGTX · Apr 2027 (est.)
Dextromethorphan-Bupropion: Early Alzheimer's Disease
Awaiting dataupdated 9mo ago
KPTI · Apr 2027 (est.)
Selinexor: Multiple Myeloma
Awaiting data
KYTX · Apr 2027 (est.)
Standard of Care Treatment: Multiple Sclerosis, Primary Progressive
Awaiting dataupdated 18mo ago
MNOV · Apr 2027 (est.)
MN-166: Amyotrophic Lateral Sclerosis
Awaiting dataupdated 4mo ago
CLDX · Apr 2027 (est.)
Barzolvolimab: Malignant Epithelial Neoplasms
Awaiting data
IOVA · Apr 2027 (est.)
Lifileucel plus Pembrolizumab: Bone Sarcoma
Awaiting data
IDYA · Apr 2027 (est.)
Darovasertib: Uveal Melanoma
Awaiting data
NBTX · Apr 2027 (est.)
NBTXR3: Radiotherapy
Awaiting dataupdated 8mo ago
NVS · Apr 2027 (est.)
Iptacopan: Generalized Myasthenia Gravis
REGN · Apr 2027 (est.)
Cemiplimab: Colon Cancer
AIM · Apr 2027 (est.)
Ampligen: Prostate Adenocarcinoma
Awaiting data
May 2027
TNGX · May 2027 (est.)
S095035: MTAP-deleted Solid Tumors
Awaiting data
VYGR · May 2027 (est.)
VY7523: Alzheimer's Disease (AD)
Awaiting dataupdated 7mo ago
REGN · May 2027 (est.)
Cemiplimab: Recurrent Ovarian Cancer
REGN · May 2027 (est.)
Cemiplimab: Non-Small Cell Lung Cancer
FDMT · May 2027 (est.)
4D-150 IVT: Choroideremia
Awaiting dataupdated 13mo ago
MBX · May 2027 (est.)
MBX 2109: Hypoparathyroidism
Awaiting dataupdated 8mo ago
June 2027
AVLN · Jun 2027 (est.)
AP01: Pulmonary Fibrosis
Awaiting data
KYMR · Jun 2027 (est.)
KT-621: Atopic Dermatitis
Awaiting data
FDMT · Jun 2027 (est.)
4D-150 IVT: Macular Neovascularization Secondary to Age-Related Macular Degeneration
Awaiting data
FTH · Jun 2027 (est.)
SNS-101: Solid Tumor, Adult
Awaiting dataupdated 10mo ago
IMMP · Jun 2027 (est.)
eftilagimod alfa: Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Awaiting data
IONS · Jun 2027 (est.)
Olezarsen: Familial Chylomicronemia Syndrome
Awaiting dataupdated 7mo ago
JAZZ · Jun 2027 (est.)
CPX-351: Acute Myeloid Leukemia
Awaiting dataupdated 11mo ago
KYTX · Jun 2027 (est.)
Standard of Care Treatment: Rheumatoid Arthritis
Awaiting dataupdated 4mo ago
NMRA · Jun 2027 (est.)
NMRA-335140: Major Depressive Disorder
Awaiting data
NVS · Jun 2027 (est.)
Remibrutinib: Hidradenitis Suppurativa
BLTE · Jun 2027 (est.)
Tinlarebant: Geographic Atrophy
Awaiting dataupdated 6mo ago
INDP · Jun 2027 (est.)
Decoy20: Solid Tumor, Adult
Awaiting dataupdated 5mo ago
July 2027
MESO · Jul 2027 (est.)
Rexlemestrocel-L: Degenerative Disc Disease
Awaiting data
VKTX · Jul 2027 (est.)
VK2735: Weight Loss
Awaiting dataupdated 7mo ago
ONCY · Jul 2027 (est.)
REOLYSIN: Anal Cancer Metastatic
Awaiting data
AMGN · Jul 2027 (est.)
ABP 938: Neovascular Age-related Macular Degeneration
August 2027
ARTV · Aug 2027 (est.)
AB-101: Lupus Nephritis - WHO Class III
Awaiting dataupdated 7mo ago
ASND · Aug 2027 (est.)
TransCon CNP: Advanced Solid Tumor
Awaiting dataupdated 4mo ago
RARE · Aug 2027 (est.)
Triheptanoin: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Awaiting data
NVCR · Aug 2027 (est.)
Temozolomide: Adenocarcinoma of Lung
Awaiting data
September 2027
BHVN · Sep 2027 (est.)
BHV-1300: Graves Disease
CHRS · Sep 2027 (est.)
CHS-1420: Hepatocellular Carcinoma
Awaiting data
CSTL · Sep 2027 (est.)
FCX-007: Dystrophic Epidermolysis Bullosa
Awaiting data
HUMA · Sep 2027 (est.)
Human Acellular Vessel: Trauma
Awaiting dataupdated 32mo ago
IMVT · Sep 2027 (est.)
IMVT-1402: Rheumatoid Arthritis
Awaiting data
TLSI · Sep 2027 (est.)
Pembrolizumab: Locally Advanced Pancreatic Adenocarcinoma
Awaiting dataupdated 12mo ago
UPB · Sep 2027 (est.)
Verekitug: Severe Asthma
Awaiting data
AGEN · Sep 2027 (est.)
Botensilimab: Metastatic Colorectal Cancer
Awaiting dataupdated 10mo ago
INCY · Sep 2027 (est.)
Corticosteroids: Chronic Graft-versus-host-disease
CNTA · Sep 2027 (est.)
cleminorexton: Narcolepsy Type 1
IVA · Sep 2027 (est.)
IVA337: NASH - Nonalcoholic Steatohepatitis
Awaiting data
MAIA · Sep 2027 (est.)
6-Thio-2'-Deoxyguanosine: Carcinoma, Non-Small-Cell Lung
Awaiting data
VNDA · Sep 2027 (est.)
Tradipitant: Motion Sickness
Awaiting data
October 2027
LLY · Oct 2027 (est.)
Tirzepatide: Obesity
OGN · Oct 2027 (est.)
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5: Esophagogastric Adenocarcinoma
Awaiting data
ONC · Oct 2027 (est.)
Zanubrutinib: Primary Membranous Nephropathy
Awaiting data
TARS · Oct 2027 (est.)
TP-03: Lyme Disease
Awaiting data
MRK · Oct 2027 (est.)
MK-8527: Human Immunodeficiency Virus (HIV)
November 2027
CRNX · Nov 2027 (est.)
Atumelnant: Congenital Adrenal Hyperplasia
ONC · Nov 2027 (est.)
BGB-3111: B-cell Malignancies
Awaiting dataupdated 8mo ago
REGN · Nov 2027 (est.)
Cemdisiran: Age-related Macular Degeneration (AMD)
MYGN · Nov 2027 (est.)
Niraparib: Solid Tumor
Awaiting dataupdated 8mo ago
ARVN · Nov 2027 (est.)
ARV-471: KRAS G12D Mutation
Awaiting data
December 2027
RARE · Dec 2027 (est.)
Triheptanoin: Medium-chain Acyl-CoA Dehydrogenase Deficiency
ANVS · Dec 2027 (est.)
buntanetap/posiphen: Early Alzheimers Disease
Awaiting data
ADAG · Dec 2027 (est.)
ADG106: HER2-negative Breast Cancer
Awaiting dataupdated 11mo ago
GOSS · Dec 2027 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INTS · Dec 2027 (est.)
INT230-6: Sarcoma,Soft Tissue
Awaiting dataupdated 11mo ago
LEGN · Dec 2027 (est.)
LCAR-B38M CAR-T Cell: Gastric Cancer
Awaiting dataupdated 7mo ago
LLY · Dec 2027 (est.)
Mirikizumab: Crohn's Disease
OTLK · Dec 2027 (est.)
bevacizumab: Age-Related Macular Degeneration
Awaiting data
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
H1 2027 (est.)
SPTX · H1 2027
SPT-300: Major Depressive Disorder (MDD)
· H1 2027
RPT904: Ig-E Mediated Food Allergy
H2 2027 (est.)
AVLN · H2 2027
AP01: Pulmonary Fibrosis
728 upcoming readouts. Source: ClinicalTrials.gov primary-completion estimates (month precision). Readout timing is not a guaranteed announcement date.

Questions

How many clinical trial readouts are tracked?

248 expected readouts are on the calendar as of September 23, 2026, each with its company-guided window and source.

Does pdufa.bio predict readout outcomes?

No. We publish dates, trial designs and measured stock reactions, each linked to its source; we do not publish outcome predictions or approval probabilities.

What is a readout?

The date a clinical trial's results become public, usually announced by the sponsor; unlike a PDUFA date it is an estimate until the company fixes it.